Ureaplasma Parvum BY PCR

The Ureaplasma Parvum BY PCR test uses polymerase chain reaction (PCR) to detect the genetic material (DNA) of Ureaplasma parvum in urogenital specimens. PCR is a highly sensitive and specific molecular method that identifies even small amounts of bacterial DNA, enabling accurate diagnosis of colonization or infection that may not be detected by culture. This test is important because Ureaplasma parvum has been associated with non-gonococcal urethritis, cervicitis, adverse pregnancy outcomes and can contribute to infertility or recurrent genitourinary symptoms.

Ureaplasma Parvum BY PCR is suitable for symptomatic individuals (men and women), partners of confirmed cases, persons undergoing fertility evaluation or prior to assisted reproductive procedures, and pregnant patients with risk factors or symptoms. The service includes discreet at-home sample collection (urine or swab where appropriate) and processing at Dubai-accredited laboratories with rapid, confidential reporting to support timely clinical decisions and targeted antimicrobial therapy when indicated.

• Ureaplasma parvum DNA (qualitative PCR)
• Cycle threshold (Ct) value (semi-quantitative indicator)
• Internal amplification control (PCR assay validity)
• Specimen type documented (urine, vaginal/endocervical, urethral swab)

• Unexplained genital or urinary symptoms (discharge, burning, dysuria)
• Recurrent urethritis, cervicitis or unexplained vaginitis/UTI symptoms
• Infertility work-up or recurrent pregnancy loss prior to fertility treatment
• Partner of a confirmed Ureaplasma case or after unprotected sexual exposure
• Pregnant women with symptoms or history of preterm labour or PROM risk

• High-sensitivity molecular detection for accurate identification
• Discreet at-home sample collection with trained phlebotomy/collection
• Fast turnaround from Dubai-accredited laboratories and secure reporting
• Confidential results enabling timely, targeted treatment and partner management
• Suitable for both men and women; useful for fertility and prenatal care pathways

• At-home collection kit provided (urine or genital swab as appropriate)
• Avoid sexual intercourse for 24–48 hours before sample collection
• Do not douche, apply topical vaginal/urethral medications, or use spermicides before sampling
• Inform the laboratory/clinician if you are currently on or recently completed antibiotics